03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Sulfentanil 50µg Hameln* : | |
Type | Medicine Non Marketed |
Originator | Sufenta 50µg* |
Agent | Pharmamed |
Distributor | Pharmamed |
Laboratory | Hameln Pharmaceuticals |
Responsible Party | Hameln Pharmaceuticals GmbH |
Origin | Germany |
Manufacturer | Hameln Pharmaceuticals Ltd |
Manufacturing Type | G |
Origin | Germany |
ATC | N01AH03 |
Sulfentanil 50µg Hameln* :
Sulfentanil 50µg Hameln* :
Sulfentanil 50µg Hameln* :
Sulfentanil 50µg Hameln* :
Sulfentanil 50µg Hameln* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abnormal ECG | Uncommon |
Anaphylactic reactions | Not known |
Anaphylactic shock | Not known |
Anaphylactoid reactions | Not known |
Apathy | Uncommon |
Apnoea (Apnea) | Not known |
Arrhythmia | Uncommon |
Ataxia | Uncommon |
Atrioventricular block (AVB) | Uncommon |
Back pain | Uncommon |
Body temperature decreased | Uncommon |
Body temperature increased | Uncommon |
Bradycardia | Uncommon |
Bronchospasm | Uncommon |
Cardiac arrest | Not known |
Cephalea | Common |
Chills | Uncommon |
Coma | Not known |
Convulsion | Not known |
Cough | Uncommon |
Cyanosis | Uncommon |
Cyanosis neonatal | Common |
Dermatitis allergic | Uncommon |
Dry skin | Uncommon |
Dysphonia | Uncommon |
Dyspnoea (dyspnea) | Uncommon |
Dystonia | Uncommon |
Erythema | Not known |
Fever | Common |
Hiccups | Uncommon |
Hyperhidrosis | Uncommon |
Hypersensitivity | Uncommon |
Hypertension | Common |
Hypertonia | Uncommon |
Hypokinesia neonatal | Uncommon |
Hyporeflexia | Uncommon |
Hypotension | Common |
Hypothermia | Uncommon |
Hypotonia neonatal | Uncommon |
Hypoventilation | Uncommon |
Injection site pain | Uncommon |
Injection site reaction | Uncommon |
Itching | Very Common |
Laryngospasm | Not known |
Lightheadedness | Common |
Miosis | Not known |
Muscle contractions involuntary | Not known |
Muscle rigidity | Uncommon |
Muscle spasms | Not known |
Muscle twitching (Muscle twitch) | Common |
Nausea | Common |
Nervousness | Uncommon |
Pain | Uncommon |
Pallor | Common |
Pigmentation disorder | Common |
Pulmonary oedema | Not known |
Respiratory arrest | Not known |
Respiratory depression | Not known |
Rhinitis | Uncommon |
Sedation | Very Common |
Shock | Not known |
Skin Eruption | Uncommon |
Somnolence | Uncommon |
Tachycardia | Common |
Tremor neonatal | Common |
Urinary incontinence | Common |
Urinary retention | Common |
Visual disturbance | Uncommon |
Vomiting | Common |
Sulfentanil 50µg Hameln* :
NB : Products With Same Indication |
Different Units By MoH Code
Sulfentanil 50µg Hameln* MoH 3545 :
Form | Solution for injection |
Packaging | Ampoules |
Package Size | 5x10ml |
Strength | 50µg/10ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 208596/03 |
Submission date | 01/01/2003 |
Registration Year | 2004 |
Archived Date | 2014 |
Price Comparison
● Country: | KSA | |
● Package Size: | 5 | |
● Public Price: | 52.6 SAR | ( 1,243,464.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 10,52 SAR | ( 236,400.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File